Clinical Trial Results:
            Effect of fixed combination of beclomethasone dipropionate/formoterol fumarate (BDP/FF), as reliever, upon exhaled nitric oxide in asthma. FENOMENO study (Fractional Exhaled Nitric Oxide-Multiple Expiration flow of NO). A single-centre, placebo controlled, randomized, double blind, cross-over study
    
|     Summary | |
|     EudraCT number | 2007-004377-26 | 
|     Trial protocol | GB | 
|     Global completion date | 
                                    25 Oct 2010
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    09 Mar 2017
                             | 
|     First version publication date | 
                                    09 Mar 2017
                             | 
|     Other versions | |
|     Summary report(s) | Statement FENOMENO Study EudraCT No 2007-004377-26 | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
